MDRO (Multi Drug Resistant Organisms) -
HSE information leaflets on MDROs
- CPE patient information
- ESBL patient information
- MRSA patient information
- Multi Drug Resistant Organism patient information
- VRE patient information
Last updated: 7 March 2019
Guidelines for Control and Prevention of Multi-Drug Resistant Organisms (MDRO) Excluding MRSA in the Healthcare Setting
Information, Data and Reports for
-
Antimicrobial Resistance and Infection Control
- Antibiotic stewardship
- Antimicrobial Resistance Surveillance
- Care Bundles
- Clostridioides difficile
-
European Antimicrobial Resistance Surveillance Network (EARS-Net)
- Latest EARS-Net Data and Reports
- EARS-Net Steering Group
- Enhanced Bacteraemia Surveillance
- EARS-Net Protocols and Forms
- Reference and Educational Resource Material
- Surveillance of Antimicrobial Consumption
-
Infection Control and Healthcare-Associated Infection
- Candida auris
-
Education/Conferences relating to Infection Control
- 2018 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course
-
2019 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course
-
Course Presentations
- 2019 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course Presentations
- 2019 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course Presentations
- 2019 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course Presentations
- 2019 RCSI/HPSC Safe Patient Care: Infection Prevention & Control Course Presentations
-
Course Presentations
- Postgraduate Courses
- Guidelines
- Hand Hygiene
- Intravascular (IV) lines
- Links
- Infection Control posters
- Publications
- Standard Precautions
-
Surveillance
- Healthcare-associated infection in long term care facilities
- HHCAI Survey 2012
-
Hospital Point Prevalence Surveys
- Prevalence Survey of Healthcare-Associated Infections 2006
- Point Prevalence Survey of Hospital-Acquired Infections & Antimicrobial Use in European Acute Care Hospitals 2012
- Point Prevalence Survey of Hospital-Acquired Infections & Antimicrobial Use in European Acute Care Hospitals 2017
- Point Prevalence Survey of Hospital-Acquired Infections & Antimicrobial Use in European Acute Care Hospitals 2023
- HPSC Surveillance
- Urinary Catheters
- GP Primary Care Setting COVID-19 video resources
- AMRIC Education Programme
- mcr-positive Enterobacteriaceae infection or colonisation
- MDRO (Multi Drug Resistant Organisms)
- Novel or rare antimicrobial resistant organism (NRAO)
-
Strategy for the control of Antimicrobial Resistance in Ireland (SARI)
-
Carbapenemase Producing Enterobacteriaceae (CPE)
- Carbapenemase-producing Enterobacteriaceae* (CPE) infection or colonisation
- Carbapenemase-producing Enterobacteriales (CPE) Expert Group
- Factsheets
- Guidance & Publications
- National pilot study of CRE in Critical Care Units, June 2011
- News
- Surveillance of CPE in Ireland
- Links
- Annual Reports
-
Carbapenemase Producing Enterobacteriaceae (CPE)
Ireland’s specialist service for the surveillance of communicable diseases.